Financial results - ALEXENT MED SRL

Financial Summary - Alexent Med Srl
Unique identification code: 32409225
Registration number: J18/541/2013
Nace: 8622
Sales - Ron
152.669
Net Profit - Ron
93.760
Employee
2
The most important financial indicators for the company Alexent Med Srl - Unique Identification Number 32409225: sales in 2023 was 152.669 euro, registering a net profit of 93.760 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Alexent Med Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 17.686 40.749 48.419 55.533 81.351 95.844 102.170 126.998 155.852 152.669
Total Income - EUR 17.940 41.469 48.419 55.534 81.352 95.844 103.204 126.998 155.853 152.669
Total Expenses - EUR 17.063 24.639 28.656 24.673 40.571 33.084 49.211 50.372 53.749 57.382
Gross Profit/Loss - EUR 877 16.830 19.763 30.861 40.781 62.760 53.993 76.626 102.104 95.287
Net Profit/Loss - EUR 345 15.586 19.279 26.983 39.967 61.802 53.151 75.382 100.545 93.760
Employees 2 2 2 2 0 2 2 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -1.7%, from 155.852 euro in the year 2022, to 152.669 euro in 2023. The Net Profit decreased by -6.480 euro, from 100.545 euro in 2022, to 93.760 in the last year.

Check the financial reports for the company - Alexent Med Srl

Rating financiar

Financial Rating -
Alexent Med Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Alexent Med Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Alexent Med Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Alexent Med Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Alexent Med Srl - CUI 32409225

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 16.883 15.512 14.472 17.928 14.237 48.906 35.377 22.271 12.505 4.506
Current Assets 8.842 23.625 42.971 66.717 83.576 101.340 86.179 148.400 206.269 137.997
Inventories 2.488 0 0 0 0 0 3 0 0 0
Receivables 2.399 2.747 3.724 3.510 4.676 5.466 71.538 72.213 79.696 81.586
Cash 3.954 20.878 39.246 63.207 78.900 95.875 14.638 76.187 126.573 56.411
Shareholders Funds 365 15.954 19.705 27.402 46.056 62.458 47.815 74.024 100.607 91.764
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 25.360 23.184 37.789 57.329 51.757 88.033 74.204 97.099 118.336 51.129
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 137.997 euro in 2023 which includes Inventories of 0 euro, Receivables of 81.586 euro and cash availability of 56.411 euro.
The company's Equity was valued at 91.764 euro, while total Liabilities amounted to 51.129 euro. Equity decreased by -8.538 euro, from 100.607 euro in 2022, to 91.764 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Alexent Med Srl

Comments - Alexent Med Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.